A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy

Publication | Closed Access

DOI

Citations

References

2012

Year

Sun Jin Sym, Junshik Hong, Jinny Park, Eun Kyung Cho, Jae Hoon Lee, Yeon Ho Park, Woon Ki Lee, Min Chung, Hyung-Sik Kim, Se Hoon Park,

Cancer Chemotherapy and Pharmacology

OncologyGastrointestinal OncologyMedicineBiweekly Irinotecan MonotherapyMetronomic TherapyPharmacotherapyCancer TreatmentFirst-line ChemotherapyPharmacologyRadiation Oncology